Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05273658Phase 2Withdrawn
Phase 2, randomised, double-blind trial (5 arms), sponsored by University of California, San Diego. Primary endpoint: Composite Drive Score at 3.5 hours. Planned start Aug 2022; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05273658.